Acceptability of switching etanercept from a prefilled syringe to an autoinjection pen.
- At: 2012 FIP Congress in Amsterdam (the Netherlands)
- Type: Poster
- By: BORRAS BLASCO, Joaquin (Hospital de Sagunto, Servicio de Farmacia, Sagunto, Spain)
- Co-author(s): Gracia-Pérez, A. (Rheumatolgy Service, Sagunto, Spain)
Rosique-Robles, J.D. (Pharmacy Department, Sagunto, Spain)
Vicient, S. (Pharmacy Department, Sagunto, Spain)
Casterá, M.D. (Pharmacy Department, Sagunto, Spain)
Abad, F.J. (Pharmacy Department, Sagunto, Spain)
To assess patients' acceptance of switching etanercept from a syringe to pen in rheumatoid arthritis patients.
A two-phase cross-sectional study. Eligible patients were=18 years and treat with etanercept syringe 50 mg sc/week for at least 6 months with an adherence>
95%. First phase consisted of a 2-h education session to present The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.